Home › Myeloproliferative Neoplasms › North Dakota
Myeloproliferative Neoplasms clinical trials in North Dakota
3 studies for Myeloproliferative Neoplasms are looking for participants at sites in North Dakota.
Cities in North Dakota
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT05564390Project: Every Child for Younger Patients With Cancer
- Sanford Broadway Medical Center, Fargo
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Fargo
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.